Staging, risk assessment and screening of breast cancer
Breast cancer is the most common female malignant disease in the western countries where a woman's lifetime risk of developing the disease is more than 10 %. Nulliparity or use of hormonal replacement therapy, strong family history, or a history of therapeutic thoracic radiation are considerabl...
Збережено в:
| Опубліковано в: : | Experimental Oncology |
|---|---|
| Дата: | 2013 |
| Автор: | |
| Формат: | Стаття |
| Мова: | English |
| Опубліковано: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2013
|
| Теми: | |
| Онлайн доступ: | https://nasplib.isofts.kiev.ua/handle/123456789/145232 |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
| Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Цитувати: | Staging, risk assessment and screening of breast cancer / B. Yalcin // Experimental Oncology. — 2013. — Т. 35, № 4. — С. 238-245. — Бібліогр.: 85 назв. — англ. |
Репозитарії
Digital Library of Periodicals of National Academy of Sciences of Ukraine| id |
nasplib_isofts_kiev_ua-123456789-145232 |
|---|---|
| record_format |
dspace |
| spelling |
Yalcin, B. 2019-01-19T17:35:10Z 2019-01-19T17:35:10Z 2013 Staging, risk assessment and screening of breast cancer / B. Yalcin // Experimental Oncology. — 2013. — Т. 35, № 4. — С. 238-245. — Бібліогр.: 85 назв. — англ. 1812-9269 https://nasplib.isofts.kiev.ua/handle/123456789/145232 Breast cancer is the most common female malignant disease in the western countries where a woman's lifetime risk of developing the disease is more than 10 %. Nulliparity or use of hormonal replacement therapy, strong family history, or a history of therapeutic thoracic radiation are considerable high risk factors for the development of breast cancer. Nowadays more new effective therapeutic agents have been developed for the intervention of the breast cancer, but prognosis is still remained poor in the metastatic disease. For the general population, screening mammography in women older than 40 - 45 years has been shown to be effective in identifying early-stage breast cancer and in decreasing the mortality rate. In randomized screening mammography trials for breast cancer, it has been established that screening mammograms reduced breast cancer mortality in women older than 50 years of age by 25 to 30%. This review article summarizes the risk factors for developing breast cancer, methods for risk assessment and the accepted screening guidelines. en Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України Experimental Oncology Special issue on breast cancer Staging, risk assessment and screening of breast cancer Article published earlier |
| institution |
Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| collection |
DSpace DC |
| title |
Staging, risk assessment and screening of breast cancer |
| spellingShingle |
Staging, risk assessment and screening of breast cancer Yalcin, B. Special issue on breast cancer |
| title_short |
Staging, risk assessment and screening of breast cancer |
| title_full |
Staging, risk assessment and screening of breast cancer |
| title_fullStr |
Staging, risk assessment and screening of breast cancer |
| title_full_unstemmed |
Staging, risk assessment and screening of breast cancer |
| title_sort |
staging, risk assessment and screening of breast cancer |
| author |
Yalcin, B. |
| author_facet |
Yalcin, B. |
| topic |
Special issue on breast cancer |
| topic_facet |
Special issue on breast cancer |
| publishDate |
2013 |
| language |
English |
| container_title |
Experimental Oncology |
| publisher |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
| format |
Article |
| description |
Breast cancer is the most common female malignant disease in the western countries where a woman's lifetime risk of developing the disease is more than 10 %. Nulliparity or use of hormonal replacement therapy, strong family history, or a history of therapeutic thoracic radiation are considerable high risk factors for the development of breast cancer. Nowadays more new effective therapeutic agents have been developed for the intervention of the breast cancer, but prognosis is still remained poor in the metastatic disease. For the general population, screening mammography in women older than 40 - 45 years has been shown to be effective in identifying early-stage breast cancer and in decreasing the mortality rate. In randomized screening mammography trials for breast cancer, it has been established that screening mammograms reduced breast cancer mortality in women older than 50 years of age by 25 to 30%. This review article summarizes the risk factors for developing breast cancer, methods for risk assessment and the accepted screening guidelines.
|
| issn |
1812-9269 |
| url |
https://nasplib.isofts.kiev.ua/handle/123456789/145232 |
| citation_txt |
Staging, risk assessment and screening of breast cancer / B. Yalcin // Experimental Oncology. — 2013. — Т. 35, № 4. — С. 238-245. — Бібліогр.: 85 назв. — англ. |
| work_keys_str_mv |
AT yalcinb stagingriskassessmentandscreeningofbreastcancer |
| first_indexed |
2025-12-07T20:05:43Z |
| last_indexed |
2025-12-07T20:05:43Z |
| _version_ |
1850881284085121024 |